Envoy Medical (NASDAQ:COCH – Get Free Report) released its earnings results on Monday. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by ($0.03), Zacks reports. The firm had revenue of $0.07 million during the quarter, compared to the consensus estimate of $0.08 million.
Envoy Medical Price Performance
NASDAQ:COCH opened at $2.60 on Wednesday. Envoy Medical has a 52-week low of $0.75 and a 52-week high of $11.72. The stock has a fifty day moving average of $2.33 and a 200 day moving average of $3.31.
Analysts Set New Price Targets
Separately, Ascendiant Capital Markets started coverage on shares of Envoy Medical in a research note on Monday, June 24th. They set a “buy” rating and a $8.50 price objective for the company.
About Envoy Medical
Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.
Further Reading
- Five stocks we like better than Envoy Medical
- About the Markup Calculator
- How to Invest in Mutual Funds
- How to Buy Cheap Stocks Step by Step
- Chipotle Mexican Grill: Take a Bite of This Smoking Hot Deal
- How to Invest in Biotech Stocks
- Why O’Reilly Automotive Stock Could Be a Long-Term Winner
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.
